Page 9 - Patrick Mccall News Today

One80 Intermediaries Launches Multi-Carrier Pricing with ClarionDoor GlobeNewswire October 11, 2022 SANTA BARBARA, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- ClarionDoor, a Zywave company, and provider of ultramodern insurance product distribution solutions, is pleased to announce a new partnership with Boston-based, One80 Intermediaries (One80) and their contract binding division at Access One80....

IN8bio (NASDAQ:INAB) chief financial officer Patrick McCall takes Proactives Stephen Gunnion through the clinical-stage biopharmaceutical...

IN8bio Partners with the Dunbar CAR T-Cell Program at the University of Louisville as the Manufacturing Center for INB-400 - read this article along with other careers information, tips and advice on BioSpace

NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing...

08.09.2022 - NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies that utilize its DeltEx platform, today announced it has ...

IN8BIO, Inc. (NASDAQ:INAB) topped the Fintel Significant Insider Buying Activity screen this week with 11 insiders buying over the last 90 days.

30.08.2022 - NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies that utilize its DeltEx platform, today announced the ...

NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and...

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and...

Investegate announcements from ClarionDoor, LLC, Coaction Global Modernizes Product Distribution with ClarionDoor